Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.
Gartrell RD, Enzler T, Kim PS, Fullerton BT, Fazlollahi L, Chen AX, Minns HE, Perni S, Weisberg SP, Rizk EM, Wang S, Oh EJ, Guo XV, Chiuzan C, Manji GA, Bates SE, Chabot J, Schrope B, Kluger M, Emond J, Rabadán R, Farber D, Remotti HE, Horowitz DP, Saenger YM. Gartrell RD, et al. Among authors: bates se. Oncoimmunology. 2022 May 5;11(1):2066767. doi: 10.1080/2162402X.2022.2066767. eCollection 2022. Oncoimmunology. 2022. PMID: 35558160 Free PMC article.
Pancreatic Cancer: Challenge and Inspiration.
Bates SE. Bates SE. Clin Cancer Res. 2017 Apr 1;23(7):1628. doi: 10.1158/1078-0432.CCR-16-2069. Clin Cancer Res. 2017. PMID: 28373360 No abstract available.
Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma".
Borazanci E, Dang CV, Robey RW, Bates SE, Chabot JA, Von Hoff DD. Borazanci E, et al. Among authors: bates se. Clin Cancer Res. 2017 Apr 1;23(7):1629-1637. doi: 10.1158/1078-0432.CCR-16-2070. Clin Cancer Res. 2017. PMID: 28373361 Review.
Neoadjuvant Treatment for Pancreatic Cancer.
Raufi AG, Manji GA, Chabot JA, Bates SE. Raufi AG, et al. Among authors: bates se. Semin Oncol. 2019 Feb;46(1):19-27. doi: 10.1053/j.seminoncol.2018.12.002. Epub 2018 Dec 28. Semin Oncol. 2019. PMID: 30630600 Review.
Base Pairs to Populations.
Bates SE. Bates SE. Clin Cancer Res. 2017 Jun 1;23(11):2610. doi: 10.1158/1078-0432.CCR-16-2631. Clin Cancer Res. 2017. PMID: 28572254 No abstract available.
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.
Van Cutsem E, Tempero MA, Sigal D, Oh DY, Fazio N, Macarulla T, Hitre E, Hammel P, Hendifar AE, Bates SE, Li CP, Hingorani SR, de la Fouchardiere C, Kasi A, Heinemann V, Maraveyas A, Bahary N, Layos L, Sahai V, Zheng L, Lacy J, Park JO, Portales F, Oberstein P, Wu W, Chondros D, Bullock AJ; HALO 109-301 Investigators. Van Cutsem E, et al. Among authors: bates se. J Clin Oncol. 2020 Sep 20;38(27):3185-3194. doi: 10.1200/JCO.20.00590. Epub 2020 Jul 24. J Clin Oncol. 2020. PMID: 32706635 Free PMC article. Clinical Trial.
420 results